During the past decade, Tyler Cardiovascular Consultants conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tyler Cardiovascular Consultants" #1 sponsor was "Bristol-Myers Squibb" with 3 trials, followed by "Medtronic Cardiac Rhythm and Heart Failure" with 3 trials sponsored, "CeloNova BioSciences, Inc." with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Angel Medical Systems" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tyler Cardiovascular Consultants" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Advanced Catheter Therapies, Inc." with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Nova Vascular LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Tyler Cardiovascular Consultants" are "Heart Failure" (3 trials), "Heart Failure, Congestive" (3 trials), "Acute Coronary Syndrome" (2 trials), "Atrial Fibrillation" (2 trials) and "Coronary Artery Disease" (2 trials). Many other conditions were trialed in "Tyler Cardiovascular Consultants" in a lesser frequency.

Most popular intervention types in "Tyler Cardiovascular Consultants" are "Device" (10 trials), "Drug" (8 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Apixaban" (3 trials), "COBRA PzF" (2 trials), "ACUITY Spiral Left Ventricular Lead" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tyler Cardiovascular Consultants" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Tyler Cardiovascular Consultants". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Tyler Cardiovascular Consultants, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Tyler Cardiovascular Consultants, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".